National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection data guide: data items and definitions 2007

National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection data guide: data items and definitions 2007

INTERNET ONLY

Phone, fax or email orders:

Internet Only

View other publications by the same author: AIHW.

View other publications in the same subject area: Alcohol and other drugs.

This data guide has been prepared as a reference for those involved in collecting and supplying data for the National Opioid Pharmacotherapy Statistics Annual Data (NOPSAD) collection. It should be particularly useful to staff in Australian Government, state and territory departments and researchers. This collection is one of a number of data sources that provide a picture of alcohol and other drug treatment services in Australia.

Authored by AIHW.

Published 11 September 2008; AIHW cat. no. WP 60; INTERNET ONLY


Download for free

Help with downloads


Full publication (147KB PDF)

  • Preliminary material
    • Title and verso pages
    • Contents
  • Sections
    1. Introduction to the NOPSAD collection
      1. Purpose of the NOPSAD data guide
      2. What is the NOPSAD collection and why was it developed?
      3. What is the NOPSAD collection used for?
    2. Scope of the NOPSAD collection
    3. NOPSAD counting rules
    4. Administrative features in each jurisdiction
    5. Data transmission, collation and reporting
    6. Data required for the NOPSAD collection
      1. Number of clients receiving pharmacotherapy drugs
      2. Number of clients by pharmacotherapy drug type and prescriber type
      3. Number of clients by pharmacotherapy drug type and dosing point site
      4. Number of pharmacotherapy prescribers
      5. Number of pharmacotherapy dosing point sites
      6. Sex of clients
      7. Age group of clients
      8. Indigenous status of clients
    7. 7 Data item definitions
      1. Prescriber
      2. Pharmacotherapy client
      3. Pharmacotherapy prescriber type
      4. Pharmacotherapy dosing point site
      5. Pharmacotherapy drug
      6. Client sex
      7. Client age group
      8. Client Indigenous status
  • End matter
  • Appendix 1: 2007 transmission specifications